IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.912
NA - Nord America 2.617
EU - Europa 1.468
SA - Sud America 54
AF - Africa 51
OC - Oceania 36
AN - Antartide 1
Totale 14.139
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.531
US - Stati Uniti d'America 2.499
HK - Hong Kong 2.038
CN - Cina 1.036
GB - Regno Unito 586
IT - Italia 262
DE - Germania 210
IN - India 120
CA - Canada 91
NL - Olanda 89
UA - Ucraina 47
JP - Giappone 46
TR - Turchia 44
FR - Francia 42
AU - Australia 35
FI - Finlandia 35
BR - Brasile 29
ES - Italia 29
ZA - Sudafrica 29
PL - Polonia 28
MX - Messico 27
CZ - Repubblica Ceca 24
PT - Portogallo 17
SE - Svezia 16
ID - Indonesia 15
AT - Austria 14
EG - Egitto 10
BD - Bangladesh 9
CL - Cile 9
AR - Argentina 8
IL - Israele 8
SA - Arabia Saudita 8
DK - Danimarca 7
IR - Iran 7
KZ - Kazakistan 7
PK - Pakistan 7
CH - Svizzera 6
BG - Bulgaria 5
EE - Estonia 5
GR - Grecia 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
JO - Giordania 4
RU - Federazione Russa 4
SN - Senegal 4
AL - Albania 3
EC - Ecuador 3
KR - Corea 3
KW - Kuwait 3
LT - Lituania 3
LU - Lussemburgo 3
OM - Oman 3
QA - Qatar 3
RS - Serbia 3
TH - Thailandia 3
BE - Belgio 2
BO - Bolivia 2
CO - Colombia 2
CY - Cipro 2
GH - Ghana 2
HU - Ungheria 2
LV - Lettonia 2
MA - Marocco 2
NG - Nigeria 2
PH - Filippine 2
SI - Slovenia 2
TN - Tunisia 2
TW - Taiwan 2
VN - Vietnam 2
AQ - Antartide 1
AZ - Azerbaigian 1
BY - Bielorussia 1
HR - Croazia 1
IQ - Iraq 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
UZ - Uzbekistan 1
Totale 14.139
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.016
Singapore 955
Ashburn 794
Boardman 611
Hefei 548
London 521
Shanghai 348
Council Bluffs 119
Los Angeles 94
Pune 94
San Francisco 83
Amsterdam 64
Munich 61
Rome 57
Toronto 55
Washington 51
Seattle 46
Tokyo 30
Santa Clara 28
New York 25
Turku 23
Ankara 22
Warsaw 22
West Jordan 20
Brno 19
Brooklyn 19
Bari 17
Montreal 15
Stockholm 14
Melbourne 13
Chicago 12
Manchester 12
Dallas 11
Helsinki 11
Naples 11
Barcelos 10
Boston 10
Guangzhou 10
Paris 10
Sydney 10
Chennai 9
Hanover 9
Johannesburg 9
Milan 9
São Paulo 9
The Dalles 9
Canberra 8
Charlotte 8
Hangzhou 8
Jinan 8
Mexico City 8
Nuremberg 8
Phoenix 8
Qingdao 8
Secaucus 8
Changsha 7
Frankfurt am Main 7
Jaguariúna 7
Madrid 7
Las Vegas 6
St Louis 6
Andover 5
Berlin 5
Bratislava 5
Cairo 5
Central 5
Oklahoma City 5
Olomouc 5
Riyadh 5
Vienna 5
Xi'an 5
Amman 4
Athens 4
Beijing 4
Bengaluru 4
Bologna 4
Buffalo 4
Dakar 4
Dublin 4
Haikou 4
Kansas City 4
Kongens Lyngby 4
Markham 4
Nanjing 4
Newark 4
Noicattaro 4
Ottawa 4
Salerno 4
State College 4
Aberdeen 3
Almaty 3
Atlanta 3
Bangkok 3
Belgrade 3
Birmingham 3
Brisbane 3
Buenos Aires 3
Centurion 3
Dhaka 3
Doha 3
Totale 7.212
Salva come PNG Salva come JPEG
Nome #
------- 206
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 201
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 197
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 192
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 188
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 185
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 178
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 175
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 175
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 165
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 159
A comprehensive review on adult onset Still's disease 159
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 158
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 157
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 152
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 151
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 146
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 145
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 145
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 141
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 131
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 118
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 104
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 98
Adult-onset Still's disease with elderly onset: results from a multicentre study 91
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 90
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 85
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 84
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 81
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 81
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 79
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 78
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 77
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 76
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 75
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 74
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 74
Cytokine storm syndrome in severe COVID-19 73
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 72
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 72
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 70
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 69
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 68
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 67
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 66
Cardiovascular disease in primary sjögren’s syndrome 63
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 62
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 60
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 52
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 50
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 48
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 46
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 45
The Vessels Contribute to Fibrosis in Systemic Sclerosis 42
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 41
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 40
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 40
The economic burden of fibromyalgia: A systematic literature review 39
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 39
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 39
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 37
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 35
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 34
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 34
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 34
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 33
Development and implementation of the AIDA International Registry for patients with Behçet's disease 32
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 31
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 31
Immunopharmacological profile of sebatic acid, a candidate for total parenteral nutrition. 31
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 31
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 30
Vitamin D and systemic lupus erythematosus - The hype and the hope 30
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 28
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 28
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 27
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 27
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 27
Potential of stem cells in the treatment of rheumatic disease 27
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 27
Neoplasie e sistema immune 27
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 27
Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study 26
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis 26
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 26
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 24
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 24
Imbalance of immune functions in progressive systemic sclerosis patients 24
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 24
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 24
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 24
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 24
Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy 23
Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren's syndrome 23
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study 23
l'immunoterapia dei tumori 23
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 23
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 23
Cyclosporin (CyA) and H2 antagonists 23
Vascular complications of scleroderma 23
Totale 7.232
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/2026669 669 0 0 0 0 0 0 0 0 0 0 0
Totale 14.288